Effect of long-term treatment with galantamine on weight of patients with Alzheimer’s dementia
- 6 December 2012
- journal article
- Published by Elsevier in The Journal of nutrition, health and aging
- p. 1-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Caution When Prescribing Cholinesterase InhibitorsJournal of the American Geriatrics Society, 2012
- Caregiver burden as a short-term predictor of weight loss in older outpatients suffering from mild to moderate Alzheimer's disease: A three months follow-up studyAging & Mental Health, 2010
- Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ EvidenceDementia and Geriatric Cognitive Disorders, 2009
- Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-upClinical Nutrition, 2009
- A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly PatientsJournal of the American Geriatrics Society, 2008
- Cholinesterase inhibitors for Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006
- Nutritional and cognitive relationships and long-term mortality in patients with various dementia disordersAge and Ageing, 2005
- Clock‐drawing and dementia in the community: A longitudinal studyInternational Journal of Geriatric Psychiatry, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975